Tag Archives: Aegerion Pharmaceuticals

← Older posts

Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More

Uncertainty related to the continued spread of the pandemic continued to consume most of the oxygen in the room this week, but life sciences news outside of that arena continued apace. Once considered all but shuttered, the IPO market again saw an active week between new public debuts and more companies joining the queue. Indeed, […]

Posted in Boston blog main, Boulder/Denver blog main, Detroit blog main, Europe blog main, Indiana blog main, National, National blog main, National top stories, New York blog main, Philadelphia Blog Main, Raleigh-Durham blog main, San Diego blog main, San Francisco blog main, Seattle blog main, Texas blog main, Wisconsin blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More

Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More

Lung injuries linked to electronic cigarettes have topped 800 cases, including 12 deaths, according to the Centers for Disease Control and Prevention. Public health officials aren’t sure whether the injuries are from legally sold products made by companies such as Juul, or from black-market items such as those that allow users to “vape” the active […]

Posted in Boston blog main, Boston top stories, Boulder/Denver blog main, Boulder/Denver top stories, Detroit blog main, Detroit top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More

Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More

The top news in biotech this week centers around one big job opening: the head seat at Biogen, now that George Scangos has announced plans to leave the company. Who takes the gig, and the strategic direction he or she chooses for Biogen will have implications not just for the company and its employees, but […]

Posted in Boston blog main, Boston top stories, Boulder/Denver blog main, Detroit blog main, Indiana blog main, National, National blog main, National top stories, New York blog main, Raleigh-Durham blog main, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Wisconsin blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More

Struggling Aegerion, QLT to Merge, Change Name to Novelion

It wasn’t too long ago that Aegerion Pharmaceuticals seemed to be a successful biotech turnaround story with its first drug on the market and optimism ahead. But just a few short years, a plummeting stock price and a new executive team later, Aegerion is about to merge with a Canadian biotech to survive. Cambridge, MA-based […]

Posted in Boston, Boston blog main, National blog main, Seattle blog main | Tagged , , , , , , , , , , , , , , , , | Comments Off on Struggling Aegerion, QLT to Merge, Change Name to Novelion

East Coast Biotech Roundup: Scangos, CRISPR, Yumanity, Synlogic & More

Biotech and pharma executives from across the country descended on frigid midtown Manhattan this week for the BIO CEO & Investor Conference, and we’ve got a few tidbits from the festivities—as well as the rest of your East Coast headlines—below. But first, a programming note. The East Coast roundup has moved to a weekly Thursday […]

Posted in Boston blog main, Boston top stories, National blog main, New York, New York blog main, New York top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on East Coast Biotech Roundup: Scangos, CRISPR, Yumanity, Synlogic & More

East Coast Biotech Roundup: Regeneron, Synergy, Foundation & More

Biotech was in recovery mode this week. After Biogen’s (NASDAQ: BIIB) disappointing quarterly results send the sector’s indices downward, investors looked to other industry stalwarts, like Gilead Sciences (NASDAQ: GILD), to right the ship (Gilead succeeded, as Alex Lash writes here). On the East Coast, a couple of New York biotechs helped the cause. Those […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, New York blog main, New York top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on East Coast Biotech Roundup: Regeneron, Synergy, Foundation & More

Beer Out as Struggling Aegerion Shuffles Leadership Ranks

It’s been a tumultuous few years for Aegerion Pharmaceuticals, marred by a stalled drug launch, the rise of new competitors, and a plummeting stock. And today its embattled CEO is leaving the company. Cambridge, MA-based Aegerion (NASDAQ: AEGR) said this morning that CEO Marc Beer has resigned, effective immediately. Chief operating officer Craig Fraser is […]

Posted in Boston, Boston blog main, Boston top stories, National blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Beer Out as Struggling Aegerion Shuffles Leadership Ranks

Eleven Bio CFO Perry Heads to Aegerion

Former Eleven Biotherapeutics (NASDAQ: EBIO) chief financial officer Gregory Perry has been named the new CFO of Aegerion Pharmaceuticals (NASDAQ: AEGR). Aside from Eleven Bio, Perry has also served in executive roles at InVivo Therapeutics, ImmunoGen, and Transkaryotic Therapeutics.    

Posted in Boston | Tagged , , , , , , , | Comments Off on Eleven Bio CFO Perry Heads to Aegerion

East Coast Biotech Roundup: NY Bio Fund, Sarepta, ZappRx, & More

Biotech clusters don’t happen overnight. Entrepreneurs, government agencies, academics, and others have to build them from the ground up. It takes years, a committed, collaborative effort, and an awful lot of money. That’s the kind of thing that’s going on in New York right now. There’s a long, long way to go, of course—Boston and […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, New York blog main, New York top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on East Coast Biotech Roundup: NY Bio Fund, Sarepta, ZappRx, & More

East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More

Between a battery of snowstorms, there was a parade this past week in Boston, as New Englanders lined the streets to celebrate Pete Carroll’s horrific goal-line call—I mean, a Patriots Super Bowl victory (congrats, Pats fans). In biotech, the theme of the week was volatility. Indices like the Nasdaq Biotechnology Index (NASDAQ: NBI) vastly underperformed […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, New York blog main, New York top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More← Older posts